Sign up to save your podcasts
Or
Share CRISPR-Based Therapy for Hereditary Angioedema
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
CRISPR-Based Therapy for Hereditary Angioedema
Explore groundbreaking advancements in treating hereditary angioedema with NTLA 2002, a revolutionary CRISPR-Cas9 therapy. Discover how this innovative one-time treatment significantly reduces attacks, offering hope for those affected by this rare condition. Original Article here.
ABOUT THE STATE OF HEALTH
The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit stateofhealth.care
FOLLOW US
View all episodes
By Medzcool
5
33 ratings
Explore groundbreaking advancements in treating hereditary angioedema with NTLA 2002, a revolutionary CRISPR-Cas9 therapy. Discover how this innovative one-time treatment significantly reduces attacks, offering hope for those affected by this rare condition. Original Article here.
ABOUT THE STATE OF HEALTH
The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit stateofhealth.care
FOLLOW US